胸主动脉腔内修复术后远期并发症:开放手术转换的作用
单中心回顾性分析8例TEVAR后转开放手术患者,指征包括持续内漏、支架移位、主动脉食管瘘等,院内死亡率50%,随访4例无死亡,提示开放转换死亡率高,应优先考虑腔内技术。
要点
- TEVAR后开放转换院内死亡率高达50%,需谨慎选择
- 开放转换指征包括持续I型内漏、III型内漏、支架移位及继发性主动脉瘘
- 开放手术需由经验丰富的开放修复外科医生完成
核心结论
- TEVAR后开放手术转换死亡率高,应优先考虑腔内技术治疗。
研究设计与样本
- 回顾性分析8例(6男)TEVAR后转开放手术患者,平均年龄55.14岁,分析指征、策略及随访结果。
主要发现
- 开放转换指征包括持续近端I型内漏伴动脉瘤增大2例、III型内漏1例、无内漏但动脉瘤增大1例、支架移位2例、继发性主动脉食管瘘1例、继发性主动脉食管及主动脉支气管瘘1例、远端动脉瘤进展2例。
- 除1例外均取出胸主动脉支架并以Dacron人工血管替换,使用左心部分体外循环。
- 院内死亡率为50%(4例),随访4例(50%)7至24个月(平均16.75个月)无死亡。
临床怎么用
- TEVAR后出现持续内漏、支架移位或继发性主动脉瘘等并发症时,开放转换死亡率高,应优先尝试腔内技术。
- 开放转换手术应由具有丰富开放修复经验的外科医生实施。
局限性
- 样本量小(8例),单中心回顾性设计,随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim was to evaluate the causes of thoracic endovascular aortic repair (TEVAR) failure and conversion to open surgery (COS) in a vascular center with high-volume open surgery and low-volume TEVAR procedures. METHODS: A total of 8 patients (6 men; mean age, 55.14 years) underwent COS after TEVAR. The indications for COS, intraoperative strategy, and early postoperative and mid-follow-up results were analyzed. RESULTS: The indications for COS were persistent proximal type I endoleak with progressive aneurysm enlargement in 2 patients, type III endoleak in 1 patient, progressive aneurysm enlargement with no endoleak in 1 patient, stent-graft migration in 2 patients, secondary aortoesophageal fistula in 1 patient, secondary aortoesophageal and aortobronchial fistula in 1 patient, and distal progression of the aneurysmal disease in 2 patients. In all but one patient, thoracic stent grafts were explanted, and replacement with a Dacron graft was performed using left partial cardiopulmonary bypass. In the remaining patients with disconnection of the distal component and unfavorable anatomy, the proximal stent graft was recycled, and the Dacron prosthesis was sewn to it. Patients with secondary aortobronchial and aortoesophageal fistulas required additional bronchial and esophageal repair. The in-hospital mortality rate was 50% (4 patients). Four (50%) patients were followed up between 7 and 24 months (mean, 16.75 months) without mortality. CONCLUSIONS: COS after TEVAR has a high mortality rate, and endovascular techniques should be considered as the first line of treatment. Those procedures should be performed by surgeons experienced in open repair which one might expect to be a challenging problem in the era of endovascular therapy.
引用
- Davidovic L, Sladojevic M, Koncar I, et al. Late Complication after Thoracic Endovascular Aortic Repair: What Is the Role of an Open Surgical Conversion? Ann Vasc Surg. 2017. PMID: 28893704. doi:10.1016/j.avsg.2017.08.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。